Literature DB >> 16820222

Preventive treatment of migraine.

Stephen D Silberstein1.   

Abstract

Migraine is a common episodic pain disorder, the treatment of which can be acute to stop an attack or preventive to reduce the frequency, duration or severity of attacks. Preventive treatment is used when attacks are frequent or disabling. Many different medication groups are used for preventive treatment, including beta-blockers, antidepressants and antiepileptic drugs. Their mechanisms of action include raising the threshold to migraine activation, enhancing antinociception, inhibiting cortical spreading depression, inhibiting peripheral and central sensitization, blocking neurogenic inflammation and modulating sympathetic, parasympathetic or 5-HT tone. In this article, I review evidence of the effectiveness of migraine preventive drugs. I also discuss the setting of treatment priorities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820222     DOI: 10.1016/j.tips.2006.06.003

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  16 in total

Review 1.  Management of headache in the elderly.

Authors:  Matthew S Robbins; Richard B Lipton
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  Lack of association between ADRA2B-4825 gene insertion/deletion polymorphism and migraine in Chinese Han population.

Authors:  Jian-Qiang Ni; Sha-Sha Jia; Min Liu; Shou-Gong Chen; Yu-Ting Jiang; Wan-Li Dong; Yu-Zhen Gao
Journal:  Neurosci Bull       Date:  2010-08       Impact factor: 5.203

3.  The pharmacological management of migraine, part 2: preventative therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-08

Review 4.  Chronic Daily Headache: Mechanisms and Principles of Management.

Authors:  Amy W Voigt; Harry J Gould
Journal:  Curr Pain Headache Rep       Date:  2016-02

5.  Immunomodulatory Effect of Toll-Like Receptor-3 Ligand Poly I:C on Cortical Spreading Depression.

Authors:  Amir Ghaemi; Azadeh Sajadian; Babak Khodaie; Ahmad Ali Lotfinia; Mahmoud Lotfinia; Afsaneh Aghabarari; Maryam Khaleghi Ghadiri; Sven Meuth; Ali Gorji
Journal:  Mol Neurobiol       Date:  2014-11-23       Impact factor: 5.590

Review 6.  Endogenous mechanisms underlying the activation and sensitization of meningeal nociceptors: the role of immuno-vascular interactions and cortical spreading depression.

Authors:  Dan Levy
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 7.  Antidepressants for the treatment of chronic pain.

Authors:  Bénédicte Verdu; Isabelle Decosterd; Thierry Buclin; Friedrich Stiefel; Alexandre Berney
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling.

Authors:  Srikanth Damodaram; Srikanth Thalakoti; Stacy E Freeman; Filip G Garrett; Paul L Durham
Journal:  Headache       Date:  2009-01       Impact factor: 5.887

9.  Association between polymorphisms in the beta2-adrenoceptor gene and migraine in women.

Authors:  Markus Schürks; Tobias Kurth; Paul M Ridker; Julie E Buring; Robert Y L Zee
Journal:  Headache       Date:  2008-07-21       Impact factor: 5.887

10.  Topiramate: safety and efficacy of its use in the prevention and treatment of migraine.

Authors:  Ginger C Minton; April D Miller; P Brandon Bookstaver; Bryan L Love
Journal:  J Cent Nerv Syst Dis       Date:  2011-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.